您当前的位置:
(R)-Lisofylline
抗炎剂,(R)-Lisofylline ((R)-Lisophylline) 是一种 Pentoxifylline 代谢产物的 (R)-型对映体,具有抗炎特性。
目录号: PC11598 纯度: ≥98%
CAS No. :100324-81-0
商品编号 规格 价格 会员价 是否有货 数量
PC11598-1mg 1mg ¥1029.00 请登录
PC11598-5mg 5mg ¥4651.08 请登录
PC11598-10mg 10mg ¥8259.44 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
(R)-Lisofylline
中文别名
1-(5-羟基己基)-3,7-二甲基嘌呤-2,6-二酮
英文名称
(R)-Lisofylline
英文别名
1H-Purine-2,6-dione,3,7-dihydro-1-[(5R)-5-hydroxyhexyl]-3,7-dimethyl-;(R)-Lisofylline;1-(5-hydroxyhexyl)-3,7-dimethyl-purine-2,6-dione;CT-1501R;Lisophylline;ProTec
Cas No.
100324-81-0
分子式
C13H20N4O3
分子量
280.32
包装储存

-20°C, stored under nitrogen

*In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)

生物活性

(R)-Lisofylline ((R)-Lisophylline) is a (R)-enantiomer of the metabolite of Pentoxifylline with anti-inflammatory properties. (R)-Lisofylline is a lysophosphatidic acid acyltransferase inhibitor with an IC50 of 0.6 μM and interrupts IL-12 signaling-mediated STAT4 activation. (R)-Lisofylline has the potential for type 1 diabetes, autoimmune disorders research.

性状

Solid

IC50 & Target[1][2]

IC50: 0.6 μM (Lysophosphatidic acid acyltransferase)
STAT4

体外研究(In Vitro)

(R)-Lisofylline blocks IL-12-driven Th1 differentiation and T cell proliferation 体外研究, yet has no effect on IL-12 secretion from APCs ex vivo or 体外研究.

Medlife has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究(In Vivo)

(R)-Lisofylline reduces the impairment of insulin secretion induced by IL-1β in cultured rat islet cells, suppresses IFN-γ production, the onset of diabetes, and macrophage infiltration into islets from NOD mice, as well as Lisofylline improves insulin response and lowers glucose levels in Streptozotocin-treated rats after the oral glucose tolerance test.
(R)-Lisofylline prevents β cell dysfunction in NOD mice by inhibition of STAT4 phosphorylation which interrupts IL-12 signaling. (R)-Lisofylline ameliorates experimental allergic encephalomyelitis in mice.
(R)-Lisofylline also improves survival in mice injected with a lethal dose of LPS and ameliorates sepsis-induced lung injury in minipigs. In rats given IL-1 intratracheally (R)-Lisofylline pretreatment reduces lung leak but does not decrease neutrophil accumulation in lungs.
(R)-Lisofylline also suppresses release of TNF-α in vivo in mice and ex vivo in human blood stimulated with endotoxin derived from Salmonella or Escherichia coli.

Medlife has not independently confirmed the accuracy of these methods. They are for reference only.

运输条件

Room temperature or refrigerated transportation.

储存方式

-20°C, stored under nitrogen

*In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)

参考文献
溶解度数据
体外研究: 

DMSO : 100 mg/mL (356.74 mM; Need ultrasonic)

配制储备溶液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 3.5674 mL 17.8368 mL 35.6735 mL
5 mM 0.7135 mL 3.5674 mL 7.1347 mL
10 mM 0.3567 mL 1.7837 mL 3.5674 mL
*

产品不同,其溶解度不同。建议根据产品选择合适的溶剂配制储备溶液;配成溶液后,建议分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (stored under nitrogen)。-80°C 储存时,建议在 6 个月内使用,-20°C 储存时,建议在 1 个月内使用。

搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2